MIND-X CORP.

Profile

Company Names

MIND-X CORP.

Addresses

4304 EAST WEST HIGHWAY, BETHESDA, MD 20814

4500 EAST WEST HIGHWAY, SUITE 125, BETHESDA, MD 20814

Phone Numbers

240-745-6606
410-878-6809

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, OTHER

Year Incorporated:

2017

State Incorporated:

MARYLAND

Total Amount Raised:

$2,250,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-12-31 
$1,750,000.00 
$5,000,000.00 
$3,250,000.00 
Equity 
1
2018-05-14 
$500,000.00 
$1,000,000.00 
$500,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EMILY 
CAPORELLO 
BLUVAS 
EXECUTIVE OFFICER
MIND-X CORP.
JULIA 
 
BROWN 
EXECUTIVE OFFICER, DIRECTOR
MIND-X CORP.
GEOFFREY 
 
LING 
DIRECTOR
MIND-X CORP.   |  SISU GLOBAL HEALTH INC.   |  CELULARITY INC
DAVID 
 
OROS 
EXECUTIVE OFFICER, DIRECTOR
GLOBAL DOMAIN VECTOR FUND LLC - SERIES A   |  GAMMA3, LLC   |  TERBIUM LABS, LLC   |  GEMSTONE BIOTHERAPEUTICS, LLC   |  TERBIUM LABS, INC.   |  MIND-X CORP.   |  ENEURA, INC.
GEORGE 
 
PETROCHEILOS 
DIRECTOR
SISU GLOBAL HEALTH INC.   |  MIND-X CORP.   |  CATALIO CREDIT OPPORTUNITIES FUND I LP   |  HAYSTACK ONCOLOGY, INC.   |  CATALIO STRUCTURED OPPORTUNITIES FUND I LP   |  CATALIO PUBLIC EQUITIES FUND, LP   |  CATALIO PUBLIC EQUITIES OFFSHORE FUND, LTD.   |  CATALIO GENESIS FUND V, LLC   |  CATALIO ACCESS FUND VII, LLC   |  CATALIO NEXUS FUND IV, LP   |  CATALIO STRUCTURED OPPORTUNITIES OFFSHORE FUND II, LP   |  CATALIO STRUCTURED OPPORTUNITIES FUND II, LP   |  CATALIO NEXUS OFFSHORE FUND IV, LP   |  CATALIO INFLECTION FUND I, LLC   |  CATALIO GENESIS FUND VI, LLC   |  CATALIO GENESIS FUND VIII, LLC   |  CATALIO GENESIS FUND IX, LLC   |  CATALIO GENESIS FUND X, LLC   |  CATALIO ACCESS FUND X, LLC   |  CATALIO ACCESS FUND IX, LLC   |  CATALIO ACCESS FUND VIII, LLC   |  CATALIO INFLECTION FUND II, LLC   |  CATALIO INFLECTION FUND III, LLC   |  CATALIO ACCESS FUND XI, LLC
R. JACOB 
 
VOGELSTEIN 
EXECUTIVE OFFICER, DIRECTOR
MIND-X CORP.   |  ENEURA, INC.   |  HAYSTACK ONCOLOGY, INC.   |  IAMBIC THERAPEUTICS, INC.   |  NEXTPOINT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-01-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-31 
2018-05-16
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2018-05-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#